This inventor holds 25 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in NMDA Receptor Modulation. Top assignees: Cadent Therapeutics, Inc., Pfizer Corporation, Novartis Ag. Active years: 2000-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
10 out of 17 
8 out of 4,488 
6 out of 3,977 
Years Active: 2000-2025
Areas of Expertise:
Title: Frank S. Menniti: Innovating Neuropsychiatric Treatments
Introduction
Frank S. Menniti, based in Mystic, CT, is a prolific inventor with a remarkable portfolio consisting of 24 patents. His work primarily focuses on the development of innovative neuropsychiatric treatments, aiming to improve the lives of individuals affected by disorders such as schizophrenia and major depressive disorder.
Latest Patents
Among his latest inventions are two noteworthy patents. The first, titled "Heteroaromatic NMDA receptor modulators and uses thereof," describes heteroaromatic compounds that hold significant promise for treating various neuropsychiatric conditions. This patent details pharmaceutical compositions and methods for utilizing these compounds to modulate the NMDA receptor effectively.
The second recent patent, "Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B," reveals compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit. This invention includes the pharmaceutical compositions derived from these compounds and outlines methodologies for treating relevant diseases.
Career Highlights
Throughout his career, Frank has made substantial contributions to the pharmaceutical industry. He has been associated with prominent companies such as Cadent Therapeutics and Pfizer Corporation, where his research and innovations have significantly advanced the field of neuropsychiatry. His expertise in drug development has solidified his reputation as a leading inventor in this domain.
Collaborations
Frank's journey in the field has seen collaborations with notable colleagues, including David R. Anderson and Robert A. Volkmann. Their joint efforts have undoubtedly enriched the research and development processes, fostering an environment of shared knowledge and innovation.
Conclusion
With an impressive record of patents and a commitment to advancing neuropsychiatric treatment methods, Frank S. Menniti stands out as a key figure in the realm of medical innovation. His contributions not only inspire fellow inventors but also bring hope to those suffering from complex mental health disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile